Market Indices
Latest News
| ||
| ||
| ||
Price Targets
Clark Wright from D.A. Davidson issued a price target of $150.00 for NICE on 2025-11-14 14:41:00.The adjusted price target was set to $150.00.At the time of the announcement,
November 14, 2025 NICE 1.06%
from JMP Securities issued a price target of $200.00 for NICE on 2025-11-14 10:48:39.The adjusted price target was set to $200.00.At the time of the announcement, NICE...
November 14, 2025 NICE 1.06%
from Barclays issued a price target of $34.00 for BILI on 2025-11-14 10:18:03.The adjusted price target was set to $34.00.At the time of the announcement, BILI was...
November 14, 2025 BILI 1.12%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CNTB Connect Biopharma Holding | 2.12
26.19% | ||||||||||||||||||
| AVDL Avadel Pharmaceuticals pl | 23.56
22.45% | ||||||||||||||||||
| QNRX Quoin Pharmaceuticals, Lt | 15.03
12.00% | ||||||||||||||||||
| NA Nano Labs Ltd | 4.70
11.11% | ||||||||||||||||||
| IMOS ChipMOS TECHNOLOGIES Inc. | 30.82
10.51% | ||||||||||||||||||
| RLX RLX Technology Inc. | 2.57
10.30% | ||||||||||||||||||
| BAK Braskem S.A. | 3.05
10.11% | ||||||||||||||||||
| CLLS Cellectis S.A. | 3.90
9.24% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT -1.26%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -0.51%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -0.42%